Vivanza Biosci.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE984E01035
  • NSEID:
  • BSEID: 530057
INR
1.91
0.07 (3.8%)
BSENSE

Apr 02

BSE+NSE Vol: 31.37 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 515837,
    "name": "Vivanza Biosci.",
    "stock_name": "Vivanza Biosci.",
    "full_name": "Vivanza Biosciences Ltd",
    "name_url": "stocks-analysis/vivanza-biosci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1.91",
    "chg": 0.07,
    "chgp": "3.8%",
    "dir": 1,
    "prev_price": "1.84",
    "mcapval": "7.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530057,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 67,
    "indexname": "",
    "isin": "INE984E01035",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "31.37 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/vivanza-biosci-515837-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 155,
    "sid": "515837",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/vivanza-biosciences-515837"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "23-Mar-2026",
      "details": "This is to Inform that pursuant to SEBI (PIT) Regulations 2015 read with the relevant Circulars issued by BSE Limited and Companies Code of Conduct for prevention of Insider Trading of the Company the Trading window for dealing in shares of the Company for all designated persons and their Immediate Relatives shall remain Closed from 1st April 2026 till 48 Hours after the Decleration of financial results for the Quarter and Year ended 31st March 2026. The date of the Board meeting for the consideration of the Financial Results of the Company for the Quarter ended 31st March 2026 will be intimated in due course.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
      "datetime": "17-Mar-2026",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 We wish to inform you that Mr. Hemant Amrish Parikh (DIN: 00027820) has tendered his resignation as Non-Executive Director of the Company vide letter dated March 17th 2026 effective from the close of business hours on the same date citing personal reasons. The details required under Regulation 30 read with SEBI Circular are provided in Annexure-A. Further the Company has received confirmation from Mr. H.A. Parikh that there are no material reasons for his resignation other than those stated in his resignation letter dated March 17 2026 which is enclosed as Annexure-B",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "17-Mar-2026",
      "details": "Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 regarding intimation of Resignation of Mr. Hemant Amrish Parikh as Non-Executive Director with Effect from 17/03/2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Vivanza Biosciences Ltd has announced <strong>1:10</strong> stock split, ex-date: 24 Mar 23",
          "dt": "2023-03-24",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Closure of Trading Window

23-Mar-2026 | Source : BSE

This is to Inform that pursuant to SEBI (PIT) Regulations 2015 read with the relevant Circulars issued by BSE Limited and Companies Code of Conduct for prevention of Insider Trading of the Company the Trading window for dealing in shares of the Company for all designated persons and their Immediate Relatives shall remain Closed from 1st April 2026 till 48 Hours after the Decleration of financial results for the Quarter and Year ended 31st March 2026. The date of the Board meeting for the consideration of the Financial Results of the Company for the Quarter ended 31st March 2026 will be intimated in due course.

Announcement under Regulation 30 (LODR)-Resignation of Director

17-Mar-2026 | Source : BSE

Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 We wish to inform you that Mr. Hemant Amrish Parikh (DIN: 00027820) has tendered his resignation as Non-Executive Director of the Company vide letter dated March 17th 2026 effective from the close of business hours on the same date citing personal reasons. The details required under Regulation 30 read with SEBI Circular are provided in Annexure-A. Further the Company has received confirmation from Mr. H.A. Parikh that there are no material reasons for his resignation other than those stated in his resignation letter dated March 17 2026 which is enclosed as Annexure-B

Announcement under Regulation 30 (LODR)-Change in Directorate

17-Mar-2026 | Source : BSE

Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 regarding intimation of Resignation of Mr. Hemant Amrish Parikh as Non-Executive Director with Effect from 17/03/2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Vivanza Biosciences Ltd has announced 1:10 stock split, ex-date: 24 Mar 23

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available